Keep the product story intact
The company should not explain one product five different ways to investors, customers, consultants, distributors, and the internal team.
得一 / De Yi
Medical device founder survival in the U.S. market.
De Yi means to obtain the one. It is the name we use for one operating discipline: keep the product's facts, evidence, claim boundaries, and next decisions aligned before serious scrutiny begins.
This section is for medical-device founders, co-founders, Chief Executive Officers (CEOs), and Chief Operating Officers (COOs) facing real operating challenges. Each note is meant to help them see the nature of the problem, separate facts from assumptions, leave with an action checklist, and decide what qualified reviewers still need to judge.
Product Identification (Product ID) means the source-backed identity of one product: what it is, who uses it, what evidence supports it, what claims stay inside the boundary, and what decisions need memory.
The simple rule
Stand where the company does not lose before it tries to win.
For a medical-device company, that means product story, public evidence, claim language, reviewer questions, and decision memory do not drift apart.
What De Yi protects
The founder does not need more noise. The founder needs the center to hold.
Separate evidence from assumptions
Public evidence, customer-known facts, internal assumptions, and open questions must stay visibly separate before external use.
Hold the claim boundary
The founder needs language the team can use, language that needs qualified review, and language that should not be used yet.
Turn each serious conversation into memory
A consultant call, investor meeting, distributor handoff, or customer question should leave a reusable record instead of another scattered note.
Field notes
We write for one group and one pressure point.
The group is medical-device founders, co-founders, and CEOs. The pressure point is U.S. market survival: staying credible and aligned before capital, customers, consultants, distributors, and reviewers turn small language mistakes into expensive problems.
- A distributor starts explaining the product beyond the claim boundary.
- An investor puts the company into the wrong category.
- A founder walks into a regulatory consultant call with scattered assumptions.
- The website, deck, and sales material describe three versions of the same product.
- A customer asks how the device differs from a public comparator.
- A product code starts replacing the actual product identity.
Founder operating articles
A separate article line for founder survival decisions.
These articles are reviewed separately from ordinary Insights articles. They are scenario-led, multilingual, source-bounded, and must end with a practical action plan for a founder-level decision.
De Yi founder decisionBefore choosing a consultant
Your Consultant Can Evaluate The FDA Path. Only You Can Test Whether Buyers Will Care.
A De Yi founder guide for using customer feedback, buyer reasons, claim boundaries, evidence burden, cost, timing, and FDA path tradeoffs to choose a sellable U.S. market-entry strategy.
From thought to product
Each note should become something a founder can use.
We are not writing to publish more content. Each serious idea should become a practical artifact that helps one founder prepare for the next conversation without losing control of the product story.
Market Entry Readiness Packet
Claim Boundary Map
Consultant Question List
Comparable Device Evidence Map
Founder Narrative Alignment Sheet
Product ID Memory Setup
Source-backed preparation, not final professional judgment.
TrueMedDevice organizes public evidence, product context, open questions, claim-boundary options, and decision memory. The company and its qualified Regulatory Affairs / Quality Assurance (RA/QA), consultant, legal, clinical, commercial, or other reviewers make the final regulatory, legal, clinical, safety, effectiveness, investment, and commercial decisions.
Prepare one product for serious review